Biomarkers of NAFLD progression: a lipidomics approach to an epidemic1[S]
暂无分享,去创建一个
Eoin Fahy | Edward A. Dennis | Alfred H. Merrill | Shankar Subramaniam | Ziqiang Guan | M. Cameron Sullards | Shakti Gupta | Christopher K. Glass | M. Kay Washington | C. Glass | M. Washington | S. Subramaniam | M. Maurya | E. Dennis | D. Russell | E. Fahy | N. Spann | H. Brown | P. Ivanova | S. Milne | R. Murphy | J. Witztum | J. McDonald | A. Merrill | Shakti Gupta | O. Quehenberger | D. Myers | D. Gorden | J. Min | Samuel L. Kelly | Jingjing Duan | M. C. Sullards | T. J. Leiker | R. Barkley | Aaron M. Armando | Thomas P Mathews | M. Armstrong | Chijun Li | W. Melvin | Ronald H. Clements | Alisha M. Mendonsa | Z. Guan | R. Clements | Robert M. Barkley | David W. Russell | Joseph L. Witztum | Oswald Quehenberger | Jingjing Duan | H. Alex Brown | Stephen B. Milne | David S. Myers | Robert C. Murphy | Jeffrey G. McDonald | Mano R. Maurya | Jun Min | D. Lee Gorden | Pavlina T. Ivanova | Nathanael J. Spann | Thomas J. Leiker | Thomas P. Mathews | Michelle D. Armstrong | Chijun Li | Willie V. Melvin | David W. Russell | Shakti S. Gupta | M. Sullards | Christopher K. Glass | M. D. Armstrong
[1] Bing-yuan Wang,et al. [Nonalcoholic fatty liver disease in the elderly]. , 2016, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.
[2] Jonathan C. Cohen,et al. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis , 2014, Hepatology.
[3] F. Goñi,et al. Biophysical properties of novel 1-deoxy-(dihydro)ceramides occurring in mammalian cells. , 2014, Biophysical journal.
[4] E. Dennis,et al. Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples. , 2014, Journal of chromatography. A.
[5] Aijaz Ahmed,et al. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. , 2014, Hepatology.
[6] A. Wree,et al. NLRP3 inflammasome activation is required for fibrosis development in NAFLD , 2014, Journal of Molecular Medicine.
[7] T. Hornemann,et al. Deoxysphingolipids, Novel Biomarkers for Type 2 Diabetes, Are Cytotoxic for Insulin-Producing Cells , 2014, Diabetes.
[8] J. Fallowfield,et al. Liver fibrosis and repair: immune regulation of wound healing in a solid organ , 2014, Nature Reviews Immunology.
[9] R. Guthke,et al. A theoretical study of lipid accumulation in the liver-implications for nonalcoholic fatty liver disease. , 2014, Biochimica et biophysica acta.
[10] April D. Lake,et al. The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.
[11] B. Lam,et al. Aberrant dolichol chain lengths as biomarkers for retinitis pigmentosa caused by impaired dolichol biosynthesis , 2013, Journal of Lipid Research.
[12] C. Glass,et al. Impact of natural genetic variation on enhancer selection and function , 2013, Nature.
[13] D. Kleiner,et al. The liver diseases of lipodystrophy: the long-term effect of leptin treatment. , 2013, Journal of hepatology.
[14] L. O’Neill,et al. How Metabolism Generates Signals during Innate Immunity and Inflammation* , 2013, The Journal of Biological Chemistry.
[15] R. Matsunuma,et al. Human Breast Cancer Tissues Contain Abundant Phosphatidylcholine(36∶1) with High Stearoyl-CoA Desaturase-1 Expression , 2013, PloS one.
[16] N. Ridgway. The role of phosphatidylcholine and choline metabolites to cell proliferation and survival , 2013, Critical reviews in biochemistry and molecular biology.
[17] S. Friedman. Liver fibrosis in 2012: Convergent pathways that cause hepatic fibrosis in NASH , 2013, Nature Reviews Gastroenterology &Hepatology.
[18] 寺谷 俊昭. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells , 2013 .
[19] C. Raetz,et al. Discovery of a cardiolipin synthase utilizing phosphatidylethanolamine and phosphatidylglycerol as substrates , 2012, Proceedings of the National Academy of Sciences.
[20] J. Kirwan,et al. Role of ceramides in nonalcoholic fatty liver disease , 2012, Trends in Endocrinology & Metabolism.
[21] J. Horowitz,et al. Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide , 2012, Diabetologia.
[22] Jun Hu,et al. OSA: a fast and accurate alignment tool for RNA-Seq , 2012, Bioinform..
[23] D. Russell,et al. A comprehensive method for extraction and quantitative analysis of sterols and secosteroids from human plasma[S] , 2012, Journal of Lipid Research.
[24] Shankar Subramaniam,et al. Gene-expression measurement: variance-modeling considerations for robust data analysis , 2012, Nature Immunology.
[25] R. Zechner,et al. Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury. , 2012, Gastroenterology.
[26] H. Brown,et al. Quantitative analysis of glycerophospholipids by LC-MS: acquisition, data handling, and interpretation. , 2011, Biochimica et biophysica acta.
[27] E. Dennis,et al. High-throughput lipidomic analysis of fatty acid derived eicosanoids and N-acylethanolamines. , 2011, Biochimica et biophysica acta.
[28] Y. Liu,et al. Analysis of mammalian sphingolipids by liquid chromatography tandem mass spectrometry (LC-MS/MS) and tissue imaging mass spectrometry (TIMS). , 2011, Biochimica et biophysica acta.
[29] E. Dennis,et al. High sensitivity quantitative lipidomics analysis of fatty acids in biological samples by gas chromatography-mass spectrometry. , 2011, Biochimica et biophysica acta.
[30] D. Billheimer,et al. Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease , 2011, Drug Metabolism and Disposition.
[31] Alfred H. Merrill,et al. Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics , 2011, Chemical reviews.
[32] L. Gan,et al. Mechanisms and Implications of Age-Related Changes in the Liver: Nonalcoholic Fatty Liver Disease in the Elderly , 2011, Current gerontology and geriatrics research.
[33] M. T. Donato,et al. A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations. , 2011, Journal of proteome research.
[34] R. Murphy,et al. Analysis of Diacylglycerol Molecular Species in Cellular Lipid Extracts by Normal-Phase LC-Electrospray Mass Spectrometry. , 2011, International journal of mass spectrometry.
[35] L. Matrisian,et al. Increased Diacylglycerols Characterize Hepatic Lipid Changes in Progression of Human Nonalcoholic Fatty Liver Disease; Comparison to a Murine Model , 2011, PloS one.
[36] P. Chambon,et al. Hypoxia‐inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis , 2011, Hepatology.
[37] Jonathan C. Cohen,et al. Human Fatty Liver Disease: Old Questions and New Insights , 2011, Science.
[38] Joel Z Stengel,et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. , 2011, Gastroenterology.
[39] Eoin Fahy,et al. Lipidomics reveals a remarkable diversity of lipids in human plasma1[S] , 2010, Journal of Lipid Research.
[40] S. Hazen,et al. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[S] , 2010, Journal of Lipid Research.
[41] Shelly C. Lu,et al. Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. , 2010, Journal of proteome research.
[42] S. Caldwell,et al. The Natural History of Non-Alcoholic Fatty Liver Disease , 2010, Digestive Diseases.
[43] W. Huber,et al. which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .
[44] R. Schinazi,et al. Simultaneous quantification of intracellular natural and antiretroviral nucleosides and nucleotides by liquid chromatography-tandem mass spectrometry. , 2010, Analytical chemistry.
[45] Michelle M Wiest,et al. The plasma lipidomic signature of nonalcoholic steatohepatitis , 2009, Hepatology.
[46] A. Diehl,et al. Apoptosis and cytokines in non-alcoholic steatohepatitis. , 2009, Clinics in liver disease.
[47] Jeremy C. Allegood,et al. Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers[S] , 2009, Journal of Lipid Research.
[48] M. Knuiman,et al. NAFLD as a Risk Factor for the Development of Diabetes and the Metabolic Syndrome: An Eleven-Year Follow-up Study , 2009, The American Journal of Gastroenterology.
[49] A. Merrill,et al. Ceramide Synthase Inhibition by Fumonisin B1 Causes Accumulation of 1-Deoxysphinganine , 2009, Journal of Biological Chemistry.
[50] Brad T. Sherman,et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.
[51] V. Darley-Usmar,et al. High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo , 2008, The Biochemical journal.
[52] G. Gores,et al. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. , 2008, Seminars in liver disease.
[53] Alexander Pertsemlidis,et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.
[54] E. Dennis,et al. Lipidomics analysis of essential fatty acids in macrophages. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.
[55] D. Houlihan,et al. Critical review of clinical trials of bone marrow stem cells in liver disease. , 2008, Gastroenterology.
[56] Alexander R. Pico,et al. WikiPathways: Pathway Editing for the People , 2008, PLoS biology.
[57] G. Musso,et al. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH , 2008, Hepatology.
[58] Robert C Murphy,et al. Separation of cellular nonpolar neutral lipids by normal-phase chromatography and analysis by electrospray ionization mass spectrometry Published, JLR Papers in Press, January 25, 2008. , 2008, Journal of Lipid Research.
[59] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[60] C. Raetz,et al. Identification of N-acylphosphatidylserine molecules in eukaryotic cells. , 2007, Biochemistry.
[61] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[62] E. Dennis,et al. Detection and quantitation of eicosanoids via high performance liquid chromatography-electrospray ionization-mass spectrometry. , 2007, Methods in enzymology.
[63] H. Brown,et al. Glycerophospholipid identification and quantitation by electrospray ionization mass spectrometry. , 2007, Methods in enzymology.
[64] M. J. Alaniz,et al. A Reliable Biomarker Derived from Plasmalogens to Evaluate Malignancy and Metastatic Capacity of Human Cancers , 2007, Lipids.
[65] Thomas Hankemeier,et al. Simultaneous quantitative analysis of metabolites using ion-pair liquid chromatography-electrospray ionization mass spectrometry. , 2006, Analytical chemistry.
[66] A. Baranova,et al. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease , 2005, Hepatology.
[67] Z. Goodman,et al. Hepatic gene expression in patients with obesity‐related non‐alcoholic steatohepatitis , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[68] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[69] E. P. Kennedy. Metabolism and function of membrane lipids , 1987, Klinische Wochenschrift.
[70] G. Marchesini,et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.
[71] D. Vance,et al. Sphingolipid Biosynthesis de Novo by Rat Hepatocytes in Culture. , 1995, The Journal of Biological Chemistry.